Delisting riskPopularity #4,178
ATYR · NASDAQ · Biotechnology

aTyr Pharma (ATYR)

Develops efzofitimod and tRNA-synthetase-derived therapies for fibrosis and inflammation.

$0.3627
vs last close+0.01 (+1.77%)